Home

WHO ARE WE 

The African Meningitis Trials Network (AMNET) was established in October 2017. The network brings together African and European Clinical Researchers whose main aim is to reduce the large number of deaths caused by meningitis in Africa through collaborative clinical rials. It is currently supported by the AMBITION Study (high dose Ambisome on a fluconazole backbone for cryptococcal meningitis induction therapy in Sub-Saharan Africa : a randomized controlled non-inferiority trial).

The objective of the Network is to build on existing experience, resources and infrastructure in order to enable other institutions and researchers to build on the AMBITION experience. The hope is that this will streamline the development of large, international randomized controlled trials in the future.

The Network includes the following partner institutions:

Botswana – Harvard Partnership  University of Cape Town University of Zimbabwe
 Infectious Diseases Institute UNC Project Malawi  Malawi – Liverpool Wellcome Trust Clinical Research Program

News: Gilead Sciences Announces Steep Discounts For Ambisome To Treat Crytococcal Meningitis in Low-and Middle-Income Countries

Gilead Sciences, Inc. has announced that it will expand its access initiatives for AmBisome® (amphotericin b liposome for injection 50 mg/vial) to address the urgent need for treatment of cryptococcal meningitis in 116 low- and middle-income countries.  Read the Full Article here on the Gilead Website.

JOB OPPORTUNITY

RESEARCH FELLOW OR ASSISTANT PROFESSOR – TRANSLATIONAL RESEARCH TO REDUCE MORTALITY FROM CNS INFECTIONS IN AFRICA


LSHTM is seeking to appoint a Research Fellow or Assistant Professor with a strong interest in international health, experience in molecular diagnostics for infectious diseases, a strong working knowledge of transcriptomics, genomics, and bioinformatic, the ability to work independently with remote supervision and a meticulous approach to research. The post-holder will work on the Translational Research to Reduce Mortality from CNS Infections in Africa study. Deadline 02 January 2019. Read More : LSHTM

SAVE THE DATE!! 3rd WORKSHOP ON AIDS-RELATED MYCOSES

NEWS

Greenwood Africa Award

The Greenwood Africa Award recognises the research achievements and future potential of a mid-career African scientist in contributing to the control of infectious disease in sub-Saharan Africa. It is awarded to an individual who shows exceptional promise as an African research leader. Deadline – 09 December 2018. Read More : LSHTM

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement Number TRIA2015-1092.

This project is part of the EDCTP2 programme supported by the European Union.